da Vinci S, Si Permanent Cautery Hook Instrument recall — FDA Z-1701-2026
Due to increased in complaints regarding frayed or broken pitch cables on reusable surgical instruments
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Due to increased in complaints regarding frayed or broken pitch cables on reusable surgical instruments
Whole-Body MR scanners used to produce images of the inside of the human body to aid diagnosis of disease may have been manufactured/serviced with ferrous (steel) fittings instead of…
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential…
Products contain cyclamates (banned sweetener)
Products contain cyclamates (banned sweetener)
Product is potentially under-processed.
The product states wild caught marine collagen and eggshell membrane collagen in ingredient statement but does not state EGG and the specific species of FISH parenthetically or via a…
Product contains undeclared milk.
Products contain cyclamates (banned sweetener)
Product is potentially under-processed.
Foreign Object (Glass)
Foreign Object (Glass)
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Failed Impurities/Degradation Specifications: out of specification at the time of testing i.e. 20th month stability testing.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Browse recent months with enough recall history for useful comparison.